David Mischoulon, MD, PhD

Commentary

Novel Approaches to Study Design and Intervention for Residual Symptoms of MDD

June 24, 2015

David Mischoulon

Letter to the Editor

Dr Mischoulon and Colleagues Reply

November 24, 2014

David Mischoulon, Lawrence H. Price, Linda L. Carpenter, et al

Original Research

A Double-Blind, Randomized Controlled Clinical Trial Comparing Eicosapentaenoic Acid Versus Docosahexaenoic Acid for Depression

September 16, 2014

David Mischoulon, Andrew A. Nierenberg, Pamela J. Schettler, et al

Original Research

A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of S-Adenosyl-l-Methionine (SAMe) Versus Escitalopram in Major Depressive Disorder

December 24, 2013

David Mischoulon, Lawrence H. Price, Linda L. Carpenter, et al

Original Research

A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Trial of Ziprasidone as Monotherapy for Major Depressive Disorder

December 15, 2012

George I. Papakostas, Ottavio V. Vitolo, Waguih W. IsHak, et al

Original Research

Bioavailability of S-Adenosyl Methionine and Impact on Response in a Randomized, Double-Blind, Placebo-Controlled Trial in Major Depressive Disorder

May 15, 2012

David Mischoulon, Jonathan E. Alpert, Erland Arning, et al

Commentary

The Impact of Omega-3 Fatty Acids on Depressive Disorders and Suicidality: Can We Reconcile 2 Studies With Seemingly Contradictory Results?

December 15, 2011

David Mischoulon

Article

Association Between Patient Beliefs Regarding Assigned Treatment and Clinical Response: Reanalysis of Data From the Hypericum Depression Trial Study Group

October 4, 2011

Justin A. Chen, George I. Papakostas, Soo Jeong Youn, et al

Original Research

Efficacy of Dose Increase Among Nonresponders to Low-Dose Aripiprazole Augmentation in Patients With Inadequate Response to Antidepressant Treatment: A Randomized, Double-Blind, Placebo-Controlled, Efficacy Trial

September 20, 2011

David Mischoulon, Janet Witte, Michael Levy, et al

ASCP Corner

Assessing the Adequacy of Past Antidepressant Trials: A Clinician's Guide to the Antidepressant Treatment Response Questionnaire

August 15, 2011

Martin Desseilles, Janet Witte, Trina E. Chang, et al

Original Research

Omega-3 for Bipolar Disorder: Meta-Analyses of Use in Mania and Bipolar Depression

August 9, 2011

Jerome Sarris, David Mischoulon, Isaac Schweitzer

Educational Activity

Evidence for Folate in Combination With Antidepressants at Initiation of Therapy

November 15, 2010

Maurizio Fava, David Mischoulon

Novel Approaches to Study Design and Intervention for Residual Symptoms of MDD

Dr Mischoulon and Colleagues Reply

A Double-Blind, Randomized Controlled Clinical Trial Comparing Eicosapentaenoic Acid Versus Docosahexaenoic Acid for Depression

A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of S-Adenosyl-l-Methionine (SAMe) Versus Escitalopram in Major Depressive Disorder

A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Trial of Ziprasidone as Monotherapy for Major Depressive Disorder

Bioavailability of S-Adenosyl Methionine and Impact on Response in a Randomized, Double-Blind, Placebo-Controlled Trial in Major Depressive Disorder

The Impact of Omega-3 Fatty Acids on Depressive Disorders and Suicidality: Can We Reconcile 2 Studies With Seemingly Contradictory Results?

Association Between Patient Beliefs Regarding Assigned Treatment and Clinical Response: Reanalysis of Data From the Hypericum Depression Trial Study Group

Efficacy of Dose Increase Among Nonresponders to Low-Dose Aripiprazole Augmentation in Patients With Inadequate Response to Antidepressant Treatment: A Randomized, Double-Blind, Placebo-Controlled, Efficacy Trial

Assessing the Adequacy of Past Antidepressant Trials: A Clinician's Guide to the Antidepressant Treatment Response Questionnaire

Omega-3 for Bipolar Disorder: Meta-Analyses of Use in Mania and Bipolar Depression

Evidence for Folate in Combination With Antidepressants at Initiation of Therapy

ELSEWHERE:

FOLLOW US:

David Mischoulon, MD, PhD

Novel Approaches to Study Design and Intervention for Residual Symptoms of MDD

Dr Mischoulon and Colleagues Reply

A Double-Blind, Randomized Controlled Clinical Trial Comparing Eicosapentaenoic Acid Versus Docosahexaenoic Acid for Depression

A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of S-Adenosyl-l-Methionine (SAMe) Versus Escitalopram in Major Depressive Disorder

A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Trial of Ziprasidone as Monotherapy for Major Depressive Disorder

Bioavailability of S-Adenosyl Methionine and Impact on Response in a Randomized, Double-Blind, Placebo-Controlled Trial in Major Depressive Disorder

The Impact of Omega-3 Fatty Acids on Depressive Disorders and Suicidality: Can We Reconcile 2 Studies With Seemingly Contradictory Results?

Association Between Patient Beliefs Regarding Assigned Treatment and Clinical Response: Reanalysis of Data From the Hypericum Depression Trial Study Group

Efficacy of Dose Increase Among Nonresponders to Low-Dose Aripiprazole Augmentation in Patients With Inadequate Response to Antidepressant Treatment: A Randomized, Double-Blind, Placebo-Controlled, Efficacy Trial

Assessing the Adequacy of Past Antidepressant Trials: A Clinician's Guide to the Antidepressant Treatment Response Questionnaire

Omega-3 for Bipolar Disorder: Meta-Analyses of Use in Mania and Bipolar Depression

Evidence for Folate in Combination With Antidepressants at Initiation of Therapy

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles